These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1743323)

  • 21. Conditioning exercise and premenstrual symptoms.
    Prior JC; Vigna Y
    J Reprod Med; 1987 Jun; 32(6):423-8. PubMed ID: 3302249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A clinical trial using danazol for the treatment of premenstrual tension.
    Watts JF; Butt WR; Logan Edwards R
    Br J Obstet Gynaecol; 1987 Jan; 94(1):30-4. PubMed ID: 3545282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of premenstrual syndrome using danazol: preliminary report of a placebo-controlled, double-blind, dose ranging study.
    Watts JF; Edwards RL; Butt WR
    J Int Med Res; 1985; 13(2):127-8. PubMed ID: 3888727
    [No Abstract]   [Full Text] [Related]  

  • 24. The efficacy of Femal in women with premenstrual syndrome: a randomised, double-blind, parallel-group, placebo-controlled, multicentre study.
    Gerhardsen G; Hansen AV; Killi M; Fornitz GG; Pedersen F; Roos SB
    Adv Ther; 2008 Jun; 25(6):595-607. PubMed ID: 18568441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induced anovulation as treatment of premenstrual tension syndrome. A double-blind cross-over study with GnRH-agonist versus placebo.
    Hammarbäck S; Bäckström T
    Acta Obstet Gynecol Scand; 1988; 67(2):159-66. PubMed ID: 3140572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gonadotropin-releasing hormone agonist in the treatment of premenstrual symptoms with and without ongoing dysphoria: a controlled study.
    Freeman EW; Sondheimer SJ; Rickels K
    Psychopharmacol Bull; 1997; 33(2):303-9. PubMed ID: 9230648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mood cyclicity in women with an without the premenstrual syndrome.
    Metcalf MG; Livesey JH; Wells JE; Braiden V
    J Psychosom Res; 1989; 33(4):407-18. PubMed ID: 2795513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Premenstrual symptoms in women with premenstrual asthma.
    Ensom MH; Chong E; Carter D
    Pharmacotherapy; 1999 Apr; 19(4):374-82. PubMed ID: 10212006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Menstrual cycle phase, menopausal transition stage, self-reports of premenstrual syndrome and symptom severity: observations from the Seattle Midlife Women's Health Study.
    Mitchell ES; Woods NF
    Menopause; 2022 Nov; 29(11):1269-1278. PubMed ID: 36194847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A double-blind trial of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome.
    Freeman EW; Rickels K; Sondheimer SJ; Polansky M
    JAMA; 1995 Jul; 274(1):51-7. PubMed ID: 7791258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The efficiency of oral contraception containing drospirenone in treating symptoms of premenstrual syndrome or premenstrual dysphoric disorder in gyneacology practice].
    Svojanovská K
    Ceska Gynekol; 2010 Oct; 75(5):474-80. PubMed ID: 21374928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Premenstrual syndrome. Tailoring treatment to symptoms.
    Nader S
    Postgrad Med; 1991 Jul; 90(1):173-80. PubMed ID: 1905806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Menstrual cycle symptom variation in a community sample of women using and not using oral contraceptives.
    Sveinsdóttir H; Bäckström T
    Acta Obstet Gynecol Scand; 2000 Sep; 79(9):757-64. PubMed ID: 10993099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychosis and the menstrual cycle.
    Dennerstein L; Judd F; Davies B
    Med J Aust; 1983 May; 1(11):524-6. PubMed ID: 6682476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder.
    Freeman EW; Kroll R; Rapkin A; Pearlstein T; Brown C; Parsey K; Zhang P; Patel H; Foegh M;
    J Womens Health Gend Based Med; 2001; 10(6):561-9. PubMed ID: 11559453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of tamoxifen with danazol for treatment of cyclical mastalgia.
    Kontostolis E; Stefanidis K; Navrozoglou I; Lolis D
    Gynecol Endocrinol; 1997 Dec; 11(6):393-7. PubMed ID: 9476088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of the effect of ovarian suppressants on women with the premenstrual syndrome: iterative spectral analysis.
    Metcalf MG; Livesey JH; Braiden V
    J Psychosom Res; 1994 Feb; 38(2):129-37. PubMed ID: 8189402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between symptom severity and hormone changes in women with premenstrual syndrome.
    Hammarbäck S; Damber JE; Bäckström T
    J Clin Endocrinol Metab; 1989 Jan; 68(1):125-30. PubMed ID: 2491857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of premenstrual syndrome with gonadotropin-releasing hormone agonist in a low dose regimen.
    Sundström I; Nyberg S; Bixo M; Hammarbäck S; Bäckström T
    Acta Obstet Gynecol Scand; 1999 Nov; 78(10):891-9. PubMed ID: 10577620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Symptom patterns in women with premenstrual syndrome complaints: a prospective assessment using a marker for ovulation and screening criteria for adequate ovarian function.
    Sveinsdottir H; Reame N
    J Adv Nurs; 1991 Jun; 16(6):689-700. PubMed ID: 1869717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.